The goal of the Proteomics/Oxidative Stress Core is two-fold. First, we will provide investigators with the equipment and technical assistance for the identification of newly discovered proteins from various tissue and cellular compartments and analysis of alterations in protein levels. Analysts and discovery of age-associated proteins in specific cellular compartments will potentially provide important new insights into pathways or metabolic processes integral to the aging process. As a second function, we will measure oxidative damage to lipids and DNA in cells and tissues using the latest and most sensitive methods and technologic approaches. Accumulation of oxidative damage to cell components with age has been proposed as a primary factor responsible for age associated alterations in physiology and pathology. Thus, it is essential that endpoints of oxidative damage be measured accurately. The measurements described above require costly equipment and technologic expertise that prevent these types of analysis as routine measures in individual laboratories. Thus, the Proteomics/Oxidative Stress Core will play an important role in allowing investigators to analyze alterations in proteins with age and will be a valuable asset for studies involved in assessing the role of oxidative damage in biological samples.
The Specific Aims of the Proteomics/Oxidative Stress Core are as follows: 1.-Identification and quantification of proteins in various sub-cellular compartments during aging. 2.-Measurement of oxidative damage to lipids and DNA through analysis of F2-isoprostanes/isofurans and 8-oxo-2-deoxyguanosine (oxoSdG), respectively. 3.-Developmental application of the novel global internal standard technology (GIST) method for mass spectrometric study of the proteome of cells/tissues.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG013319-12
Application #
7309796
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
12
Fiscal Year
2006
Total Cost
$85,068
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Type
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Hook, Michael; Roy, Suheeta; Williams, Evan G et al. (2018) Genetic cartography of longevity in humans and mice: Current landscape and horizons. Biochim Biophys Acta Mol Basis Dis 1864:2718-2732
Van Skike, Candice E; Galvan, Veronica (2018) A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review. Gerontology 64:205-211
Kraig, Ellen; Linehan, Leslie A; Liang, Hanyu et al. (2018) A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects. Exp Gerontol 105:53-69
Ungvari, Zoltan; Tarantini, Stefano; Donato, Anthony J et al. (2018) Mechanisms of Vascular Aging. Circ Res 123:849-867
Weiss, Roxanne; Fernandez, Elizabeth; Liu, Yuhong et al. (2018) Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice. Aging (Albany NY) :
Qin, Kunhua; Zhang, Ning; Zhang, Zhao et al. (2018) SIRT6-mediated transcriptional suppression of Txnip is critical for pancreatic beta cell function and survival in mice. Diabetologia 61:906-918
Salmon, Adam B; Dorigatti, Jonathan; Huber, Hillary F et al. (2018) Maternal nutrient restriction in baboon programs later-life cellular growth and respiration of cultured skin fibroblasts: a potential model for the study of aging-programming interactions. Geroscience 40:269-278
Gelfond, Jonathan; Goros, Martin; Hernandez, Brian et al. (2018) A System for an Accountable Data Analysis Process in R. R J 10:6-21
Sills, Aubrey M; Artavia, Joselyn M; DeRosa, Brian D et al. (2018) Long-term treatment with the mTOR inhibitor rapamycin has minor effect on clinical laboratory markers in middle-aged marmosets. Am J Primatol :e22927
Xu, Ming; Pirtskhalava, Tamar; Farr, Joshua N et al. (2018) Senolytics improve physical function and increase lifespan in old age. Nat Med 24:1246-1256

Showing the most recent 10 out of 231 publications